PlainRecalls
FDA Drug Critical Class I Terminated

Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg / 50 mL (4 mcg / mL), 50 mL Single Dose Bottle, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-671-05

Reported: December 16, 2020 Initiated: November 17, 2020 #D-0120-2021

Product Description

Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg / 50 mL (4 mcg / mL), 50 mL Single Dose Bottle, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-671-05

Reason for Recall

Cross Contamination with other products: trace amounts of lidocaine

Details

Recalling Firm
Fresenius Kabi USA, LLC
Units Affected
13,525 bottles
Distribution
USA Nationwide
Location
Lake Zurich, IL

Frequently Asked Questions

What product was recalled?
Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg / 50 mL (4 mcg / mL), 50 mL Single Dose Bottle, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-671-05. Recalled by Fresenius Kabi USA, LLC. Units affected: 13,525 bottles.
Why was this product recalled?
Cross Contamination with other products: trace amounts of lidocaine
Which agency issued this recall?
This recall was issued by the FDA Drug on December 16, 2020. Severity: Critical. Recall number: D-0120-2021.